164 related articles for article (PubMed ID: 37771131)
1. Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Xia M; Song X; Lu Z; Wang Y; Zhou Q; Geng P; Wang S; Zhou Y; Wu Q; Han A
Thorac Cancer; 2023 Nov; 14(33):3331-3341. PubMed ID: 37771131
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
Shen L; Wang J; Yi Y; Ye C; Wang R; Xia G; Yu C; Tu F; Xu J; Zheng Z
Drug Test Anal; 2019 Apr; 11(4):595-600. PubMed ID: 30370647
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats.
Wang L; Wang S; Chen M; Chen X; Lin Y; Hu X; Huang X; Li X; Hu G
Drug Dev Ind Pharm; 2015; 41(10):1661-6. PubMed ID: 25417773
[TBL] [Abstract][Full Text] [Related]
4. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Moody DE; Liu F; Fang WB
J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC-MS/MS.
Wang S; Xia M; Wang Y; Lu Z; Geng P; Dai D; Zhou Y; Wu Q
Thorac Cancer; 2023 May; 14(14):1276-1285. PubMed ID: 36973912
[TBL] [Abstract][Full Text] [Related]
6. Studies on the inhibitory effect of isavuconazole on flumatinib metabolism
Liu YN; Xu X; Nie J; Hu Y; Xu X; Xu RA; Du X
Front Pharmacol; 2023; 14():1168852. PubMed ID: 37214442
[TBL] [Abstract][Full Text] [Related]
7. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Chen M; Zhang X; Chen Y; Sun W; Wang Z; Huang C; Hu G; Chen R
Xenobiotica; 2020 Mar; 50(3):280-287. PubMed ID: 31199171
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419
[TBL] [Abstract][Full Text] [Related]
10. Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma.
Ye Z; Wang C; Li R; Chen C; Yang J; Chen Y; Fu J; Zhou T; Jin M; Huang A; Zhang X; Zhou Z
J Pharm Pharmacol; 2024 Jan; 76(2):115-121. PubMed ID: 38150242
[TBL] [Abstract][Full Text] [Related]
11. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G
Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505
[TBL] [Abstract][Full Text] [Related]
12. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
[TBL] [Abstract][Full Text] [Related]
13. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z
Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818
[TBL] [Abstract][Full Text] [Related]
14. The variability in CYP3A4 activity determines the metabolic kinetic characteristics of ketamine.
Li M; Li Q; Lin D; Zheng X; Jin L; Cai J; Hu G; Qian J
Toxicology; 2023 Dec; 500():153682. PubMed ID: 38006927
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ketoconazole on the Pharmacokinetics of Lenvatinib (E7080) in Healthy Participants.
Shumaker R; Aluri J; Fan J; Martinez G; Thompson GA; Ren M
Clin Pharmacol Drug Dev; 2015 Mar; 4(2):155-160. PubMed ID: 26097795
[TBL] [Abstract][Full Text] [Related]
16. Effect of
Wang Y; Zhou Q; Wang H; Song W; Wang J; Mamun AA; Geng P; Zhou Y; Wang S
Front Pharmacol; 2024; 15():1351882. PubMed ID: 38650629
[TBL] [Abstract][Full Text] [Related]
17. The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
Zhou Q; Ye F; Ye Z; Gao N; Kong Q; Hu X; Qian J; Wu B
PeerJ; 2023; 11():e16601. PubMed ID: 38089912
[TBL] [Abstract][Full Text] [Related]
18. Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib
Zhou S; Zhao FL; Wang SH; Wang YR; Hong Y; Zhou Q; Geng PW; Luo QF; Cai JP; Dai DP
Pharm Biol; 2023 Dec; 61(1):356-361. PubMed ID: 36728978
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of ketoconazole, fluconazole, and itraconazole on the pharmacokinetics of pyrotinib
Wang L; Wu F; Xu J; Wang Y; Fei W; Jiang H; Geng P; Zhou Q; Wang S; Zheng Y; Deng H
Front Pharmacol; 2022; 13():962731. PubMed ID: 36160438
[TBL] [Abstract][Full Text] [Related]
20. Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.
Bao SS; Tang PF; Gao NY; Xiao ZX; Qian JC; Zheng L; Hu GX; Xu HH
PeerJ; 2023; 11():e16051. PubMed ID: 37719112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]